# Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure

> **NCT01055912** · PHASE2 · COMPLETED · sponsor: **CardioKine Inc.** · enrollment: 170 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** Lixivaptan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01055912
- **Lead sponsor:** CardioKine Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-09
- **Final completion:** —
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2011-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01055912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01055912, "Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01055912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*